Welcome to our dedicated page for Myseum SEC filings (Ticker: MYSE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Myseum's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Myseum's regulatory disclosures and financial reporting.
Myseum, Inc. (MYSE) filed its Q3 2025 10‑Q, showing minimal net revenues of $328 and a net loss of $1,231,481, or $0.28 per share. Operating expenses were $1,280,929, offset partly by $49,120 of interest income.
As of September 30, 2025, cash and cash equivalents were $457,626 and short‑term investments were $4,346,310, with working capital of $4,193,316. The company recorded a right‑of‑use lease asset of $244,793 and related lease liabilities. Research and development expense declined year over year.
In January 2025, Myseum sold 1,200,000 common shares at $4.25 for net proceeds of $4,532,000, and in February established an at‑the‑market program to sell up to $6,000,000 of common stock. Shares outstanding were 4,264,329 as of November 13, 2025.
Myseum, Inc. filed a Form S-8 to register securities for issuance under its Amended and Restated 2021 Omnibus Equity Incentive Plan. The filing is an administrative step that allows the company to issue equity to eligible participants under the plan.
Recipients of awards under the plan will receive a Section 10(a) prospectus as provided by Rule 428(b)(1). The filing lists Myseum’s Nevada incorporation and designates the Chief Executive Officer, Darin Myman, as agent for service at the company’s New Brunswick, NJ address.
Myseum, Inc. filed a Form 8-K announcing management’s presentation materials, to be used on and after November 4, 2025, and furnished them as Exhibit 99.1. The company notes the materials are summary information and speak as of their date, and it disclaims any obligation to update them.
As context, Myseum’s securities listed on Nasdaq include Common Stock (MYSE) and Series A Warrants (MYSEW), with each warrant exercisable for one share of common stock at an exercise price of $49.80.
Myseum, Inc. (MYSE) reported that it received a USPTO notice of allowance for patent application #18/487,726 titled “Secure Web RTC Real Time Communications Service for Audio and Video Streaming Communications.” The company disclosed the news in an 8-K and furnished a related press release as an exhibit.
The notice of allowance indicates the USPTO plans to grant a patent following final administrative steps. A press release dated October 16, 2025 is attached as Exhibit 99.1.
Myseum, Inc. (MYSE) reported a new patent grant in Israel. The company announced that the Israel Patent Office has granted patent no. 290546 for its invention titled “Systems and Methods of Transforming Electronic Content.” The disclosure was made via an 8-K under “Other Events,” with a press release furnished as Exhibit 99.1.
The filing highlights intellectual property progress tied to Myseum’s content transformation technology. The company’s common stock trades on Nasdaq under MYSE; Series A Warrants trade as MYSEW.
Myseum, Inc. filed a Form 8-K reporting a material event tied to a press release dated
Darin Myman, Chief Executive Officer and Director of Myseum, Inc., reported purchases of common stock on 09/19/2025. The Form 4 shows three purchase transactions: 300 shares at $2.145, 1,000 shares at $2.15 and 2,700 shares at $2.1695, totaling 4,000 shares acquired the same day. Following those transactions the report lists beneficial ownership rising from 190,816 to 194,516 shares.
The filing also reports an indirect interest noted "By spouse" and includes a standard disclaimer that the reporting person disclaims beneficial ownership of the securities listed. The form is signed and dated 09/19/2025.
FAQ
What is the current stock price of Myseum (MYSE)?
What is the market cap of Myseum (MYSE)?
